Extended Data Table 3 Evaluation of the added value of dd-cfDNA when associated with standard of care parameters (eGFR and proteinuria at time of evaluation, anti-HLA DSA, previous episode of rejection, kidney graft instability), in different clinical scenarios

From: Cell-free DNA for the detection of kidney allograft rejection

Back to article page